IMR Press / CEOG / Volume 24 / Issue 3 / pii/1997043

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research

Allotypes and gynecological cancer

Show Less
1 Associate Professor in Biology, Laboratory of General Biology, Aristotelian University of Thessaloniki (Greece)
2 Associate Professor in Obstetrics and Gynecology, 4th Department of Obstetrics and Gynecology, Arisiotelian University of Thessaloniki (Greece)
3 Lecturer in Obstetrics and Gynecology,4th Department of Obsietrics and Gynecology, Aristotelian University of Thessaloniki (Greece)
4 Professor and Head of the Laboratory of General Biology, Aristotelian University of Thessaloniki (Greece)
Clin. Exp. Obstet. Gynecol. 1997, 24(3), 138–140;
Published: 10 September 1997
Abstract

Purpose: To investigate if gynecologic cancer patients have different immune responses. Methods: Immunoglobulin heavy chains (G1m, G3m), Kappa light chains (Km) and allotype and phenotype frequencies were examined in 58 patients with gynecologic cancer (ovarian, cervical, endometrial, vulval, vaginal and uterine sarcoma) and a control group of 26 women. Results: No significant differences were found between the different allotype or phenotype frequencies between the two groups. Conclusions: Our results indicate that Gm and Km allotypes do not represent susceptibility factors for gynecologic cancer in Caucasians.

Keywords
Immunoglobulin allotypes-gynecological cancer-genetics
Share
Back to top